Dr. Pagani Discusses Aromatase Inhibitors For Premenopausal Women With Breast Cancer

Dr. Pagani Discusses Aromatase Inhibitors for Premenopausal Women with Breast Cancer

Treating Breast Cancer in Premenopausal Women

Targeted Oncology

Evaluating endocrine therapy in pre-menopausal women with breast cancer

Breast cancer: Adjuvant exemestane combined with ovarian function suppression better than tamoxifen

Aromatase Inhibitors: What They Are And How They Work with Dr Liz O'Riordan

Dr Liz O'Riordan

Dr. Harvey on Aromatase Inhibitor Treatment Duration

Dr. Judy Garber and aromatase inhibitors for breast cancer prevention | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Dr. Rao on the SOFT Trial in Patients With Premenopausal Breast Cancer

Aromatase Inhibitors in Breast Cancer Survivors

Mayo Proceedings

Should I Take an Aromatase Inhibitor? (5 Things Breast Cancer Survivors Are Not Told)

Dr. Amy - Cancer Expert & Cancer Survivor

Ovarian function suppression in premenopausal women with breast cancer

Dr. Melisko on Duration of Aromatase Inhibitor Use in Breast Cancer

How to cope with Tamoxifen and Letrozole

Dr Liz O'Riordan

Aromatase Inhibitors & Breast Cancer Therapy - Milestones in Oncology

The Society for Translational Oncology

Aromatase Inhibitors: A Complete Guide for Breast Cancer Patients

Yerbba – Breast Cancer

What are Aromatase Inhibitors?

Dr Liz O'Riordan

Dr. O'Regan on Treatment of Breast Cancer in Premenopausal Women

Elaine Mardis on Predictive Markers for Sensitivity to Aromatase Inhibitors in Breast Cancer

Ovarian Suppression in Metastatic HR+ Breast Cancer

An Overview of the MA17R Trial in Breast Cancer

Targeted Oncology